Lantern Pharma
Selin Ergulen is a Clinical Trial Project Manager at Lantern Pharma Inc. since June 2024, with prior experience as a Clinical Trial Manager at DAVA Oncology from February 2021 to June 2024, managing day-to-day operations of late Phase III Oncology studies and handling regulatory submissions. Earlier roles include a Health Technology Writer Intern at Helpsy Health and an Undergraduate Research Assistant at Rice University, where Selin synthesized fluorescent surfactants for the visualization of Boron Nitride Nanotubes. Selin holds a Master of Science in Bioscience and Health Policy and a Bachelor of Science in Chemistry from Rice University, with a specialization in inorganic chemistry, and completed a science and math track at Hisar School.
This person is not in any teams
Lantern Pharma
24 followers
Lantern Pharma, Inc. is a clinical-stage pharmaceutical company developing new classes of precision cancer drugs with novel mechanisms of action, and also rescuing or revitalizing abandoned or failed cancer drugs using machine learning techniques, genomic data, and precision oncology trials. Lantern is focused on accelerating personalized cancer therapy development through the use of AI and genomic-based patient stratification.